$0.7801
-0.0949-10.85%
Last update: Nov 6, 4:35 AM
Telomir Pharmaceuticals Inc
TELONASDAQ
The average analyst price target for Telomir Pharmaceuticals is $4, 412.2% above the current price. The one analyst covering it rates it Buy. The latest change came on Sep 17, 2026, when Maxim Group initiated coverage of Telomir Pharmaceuticals with a Buy rating and a $4 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
